The University of Southampton
University of Southampton Institutional Repository

Targeting cancer associated fibroblasts to enhance immunotherapy: emerging strategies and future perspectives

Targeting cancer associated fibroblasts to enhance immunotherapy: emerging strategies and future perspectives
Targeting cancer associated fibroblasts to enhance immunotherapy: emerging strategies and future perspectives

Cancer associated fibroblasts are a prominent component of the tumour microenvironment in most solid cancers. This heterogeneous population of cells are known to play an important role in tumour progression and recent studies have demonstrated that CAFs may confer resistance to checkpoint immunotherapy, suggesting that targeting these cells could improve response rates. However, effective clinical strategies for CAF targeting have yet to be identified. In this editorial, we highlight current limitations in our understanding of CAF heterogeneity, and discuss the potential and possible approaches for CAF-directed therapy.

Cancer associated fibroblasts, Immunotherapy, Tumour microenvironment
1949-2553
1427-1433
Hanley, Christopher J.
7e2d840d-e724-4389-a362-83741ccdf241
Thomas, Gareth J.
2ff54aa9-a766-416b-91ee-cf1c5be74106
Hanley, Christopher J.
7e2d840d-e724-4389-a362-83741ccdf241
Thomas, Gareth J.
2ff54aa9-a766-416b-91ee-cf1c5be74106

Hanley, Christopher J. and Thomas, Gareth J. (2021) Targeting cancer associated fibroblasts to enhance immunotherapy: emerging strategies and future perspectives. Oncotarget, 12 (14), 1427-1433. (doi:10.18632/oncotarget.27936).

Record type: Article

Abstract

Cancer associated fibroblasts are a prominent component of the tumour microenvironment in most solid cancers. This heterogeneous population of cells are known to play an important role in tumour progression and recent studies have demonstrated that CAFs may confer resistance to checkpoint immunotherapy, suggesting that targeting these cells could improve response rates. However, effective clinical strategies for CAF targeting have yet to be identified. In this editorial, we highlight current limitations in our understanding of CAF heterogeneity, and discuss the potential and possible approaches for CAF-directed therapy.

This record has no associated files available for download.

More information

Published date: 6 July 2021
Additional Information: Copyright: © 2021 Hanley and Thomas.
Keywords: Cancer associated fibroblasts, Immunotherapy, Tumour microenvironment

Identifiers

Local EPrints ID: 452846
URI: http://eprints.soton.ac.uk/id/eprint/452846
ISSN: 1949-2553
PURE UUID: 71c17804-fa7f-42fe-b248-d43bcdc936ce
ORCID for Christopher J. Hanley: ORCID iD orcid.org/0000-0003-3816-7220

Catalogue record

Date deposited: 21 Dec 2021 17:55
Last modified: 17 Mar 2024 03:37

Export record

Altmetrics

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×